Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Fluticasone (inhaled - ICS)

4

XVII.a Respiratory tract infection incl. pneumonia

3
Last update : 18/10/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Corticosteroids, inhaled (ICS)
5

Publications

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
The New England journal of medicine 2018 May 03;378;1671-1680 2018 May 03
Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
International journal of chronic obstructive pulmonary disease 2017;12;3055-3064 2017
Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.
Annals of the American Thoracic Society 2015 Jan;12;27-34 2015 Jan
Meta-review: adverse effects of inhaled corticosteroids relevant to older patients.
Drugs 2014 Apr;74;539-47 2014 Apr
Inhaled corticosteroids in COPD and the risk of serious pneumonia.
Thorax 2013 Nov;68;1029-36 2013 Nov

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies